Roche Pharmaceutical Development and Sales Overview slide image

Roche Pharmaceutical Development and Sales Overview

Pathology Lab CER-Constant Exchange Rates CHFbn 1.2 2022 vs. 2021 CER growth +10% 1.0 0.8 0.6 0.4 0.2 0.0 YTD Sep 2020 YTD Sep 2021 YTD Sep 2022 Advanced Staining Primary Staining +28% +4% +8% Companion Diagnostics Roche 175
View entire presentation